Slomovitz BM - Search Results

1

Efficacy of letrozole in the treatment of recurrent platinum- and taxane-resistant high-grade cancer of the ovary or peritoneum.

Ramirez PT, Schmeler KM, Milam MR, Slomovitz BM, Smith JA, Kavanagh JJ, Deavers M, Levenback C, Coleman RL, Gershenson DM. Ramirez PT, et al. Among authors: slomovitz bm. Gynecol Oncol. 2008 Jul;110(1):56-9. doi: 10.1016/j.ygyno.2008.03.014. Epub 2008 May 5. Gynecol Oncol. 2008. PMID: 18457865 Clinical Trial.

2

Updates in the Use of Targeted Therapies for Gynecologic Cancers.

Cantillo E, Blanc-Durand F, Leary A, Slomovitz BM, Fuh K, Washington C. Cantillo E, et al. Among authors: slomovitz bm. Am Soc Clin Oncol Educ Book. 2024 Jun;44(3):e438582. doi: 10.1200/EDBK_438582. Am Soc Clin Oncol Educ Book. 2024. PMID: 38788185 Free article. Review.

3

Desmoplastic small round cell tumor with primary ovarian involvement: case report and review.

Slomovitz BM, Girotra M, Aledo A, Saqi A, Soslow RA, Spigland NA, Caputo TA. Slomovitz BM, et al. Gynecol Oncol. 2000 Oct;79(1):124-8. doi: 10.1006/gyno.2000.5829. Gynecol Oncol. 2000. PMID: 11006044 Review.

4

Serous adenocarcinoma of the inguinal region arising from endometriosis followed by a successful pregnancy.

Slomovitz BM, Soslow RA, Chang RC, Golub R, Kuo DY. Slomovitz BM, et al. Gynecol Oncol. 2002 Oct;87(1):152-4. doi: 10.1006/gyno.2002.6790. Gynecol Oncol. 2002. PMID: 12468359

5

Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases.

Slomovitz BM, Burke TW, Eifel PJ, Ramondetta LM, Silva EG, Jhingran A, Oh JC, Atkinson EN, Broaddus RR, Gershenson DM, Lu KH. Slomovitz BM, et al. Gynecol Oncol. 2003 Dec;91(3):463-9. doi: 10.1016/j.ygyno.2003.08.018. Gynecol Oncol. 2003. PMID: 14675663 Review.

6

Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.

Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH. Slomovitz BM, et al. J Clin Oncol. 2004 Aug 1;22(15):3126-32. doi: 10.1200/JCO.2004.11.154. J Clin Oncol. 2004. PMID: 15284264

7

Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer?

Slomovitz BM, Sun CC, Ramirez PT, Bodurka DC, Diaz P, Lu KH. Slomovitz BM, et al. Obstet Gynecol. 2004 Aug;104(2):255-60. doi: 10.1097/01.AOG.0000131620.67911.03. Obstet Gynecol. 2004. PMID: 15291996

8

Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases.

Soliman PT, Slomovitz BM, Broaddus RR, Sun CC, Oh JC, Eifel PJ, Gershenson DM, Lu KH. Soliman PT, et al. Among authors: slomovitz bm. Gynecol Oncol. 2004 Aug;94(2):456-62. doi: 10.1016/j.ygyno.2004.05.006. Gynecol Oncol. 2004. PMID: 15297188 Review.

9

Expression of imatinib mesylate-targeted kinases in endometrial carcinoma.

Slomovitz BM, Broaddus RR, Schmandt R, Wu W, Oh JC, Ramondetta LM, Burke TW, Gershenson DM, Lu KH. Slomovitz BM, et al. Gynecol Oncol. 2004 Oct;95(1):32-6. doi: 10.1016/j.ygyno.2004.06.052. Gynecol Oncol. 2004. PMID: 15385107

10

Risk factors for young premenopausal women with endometrial cancer.

Soliman PT, Oh JC, Schmeler KM, Sun CC, Slomovitz BM, Gershenson DM, Burke TW, Lu KH. Soliman PT, et al. Among authors: slomovitz bm. Obstet Gynecol. 2005 Mar;105(3):575-80. doi: 10.1097/01.AOG.0000154151.14516.f7. Obstet Gynecol. 2005. PMID: 15738027

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

141 results

Search Page

Filters